Back
GoodRx Holdings Vs. National Research Industry Stock Comparison
Sell
34
GDRX
GoodRx Holdings
Last Price:
5.02
Seasonality Move:
-6.95%
Sell
28
NRC
National Research
Last Price:
20.00
Seasonality Move:
-0.56%
Sell
34
GoodRx Holdings (GDRX)
is a Sell
Is GoodRx Holdings a Buy, Sell or Hold?
- The current GoodRx Holdings [GDRX] share price is $6.10. The Score for GDRX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- GDRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
National Research (NRC)
is a Sell
Is National Research a Buy, Sell or Hold?
- The current National Research [NRC] share price is $20.42. The Score for NRC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- NRC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GDRX Stock Price Chart
What is GoodRx Holdings's stock price today?
-
The GoodRx Holdings share price today is $6.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDRX is experiencing slight selling pressure.
NRC Stock Price Chart
What is National Research's stock price today?
-
The National Research share price today is $20.42
The current trend is relatively stagnant and NRC is experiencing buying pressure, which is a positive indicator for future bullish movement.
GDRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 35.77 | Sell |
Chaikin Money Flow: | -206635 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.22 - 7) | Sell |
Bollinger Bands (100): | (6.74 - 8.34) | Sell |
NRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.44 | Sell |
Relative Strength Index (14 RSI): | 59.28 | Buy |
Chaikin Money Flow: | 51052 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.21 - 19.87) | Buy |
Bollinger Bands (100): | (19.78 - 23.96) | Sell |
GDRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.17 | Sell |
20-day SMA: | 6.5 | Sell |
50-day SMA: | 7.05 | Sell |
200-day SMA: | 7.3 | Sell |
8-day EMA: | 6.15 | Sell |
20-day EMA: | 6.43 | Sell |
50-day EMA: | 6.88 | Sell |
200-day EMA: | 7.16 | Sell |
NRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.6 | Buy |
20-day SMA: | 18.78 | Buy |
50-day SMA: | 20.52 | Sell |
200-day SMA: | 28.72 | Sell |
8-day EMA: | 18.93 | Buy |
20-day EMA: | 19.09 | Buy |
50-day EMA: | 20.31 | Buy |
200-day EMA: | 27.18 | Sell |
GoodRx Holdings Earnings Growth & GDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.09 per share.
National Research Earnings Growth & NRC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
GoodRx Holdings Technical Analysis
Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
National Research Technical Analysis
Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |